ArticleBioengineering (Basel, Switzerland)2025
Simplatab: An Automated Machine Learning Framework for Radiomics-Based Bi-Parametric MRI Detection of Clinically Significant Prostate Cancer.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Automated Machine Learning Frameworks for Radiomics: Comparative Evaluation Study.JMIR formative research · 2026Article
- Traditional machine learning in biomedical image analysis: before you go too deep.Frontiers in artificial intelligence · 2026Review
- Beyond Radiomics Alone: Enhancing Prostate Cancer Classification with ADC Ratio in a Multicenter Benchmarking Study.Diagnostics (Basel, Switzerland) · 2025Article
- Artificial Intelligence for Multiscale Spatial Analysis in Oncology: Current Applications and Future Implications.International journal of molecular sciences · 2025Review
- Liver Cancer: Artificial Intelligence (AI)-Based Integrated Therapeutic Approaches.Bioengineering (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundProstate cancer (PCa) diagnosis using MRI is often challenged by lesion variability.
methodsThis study introduces Simplatab, an open-source automated machine learning (AutoML) framework designed for, but not limited to, automating the entire machine Learning pipeline to facilitate the detection of clinically significant prostate cancer (csPCa) using radiomics features. Unlike existing AutoML tools such as Auto-WEKA, Auto-Sklearn, ML-Plan, ATM, Google AutoML, and TPOT, Simplatab offers a comprehensive, user-friendly framework that integrates data bias detection, feature selection, model training with hyperparameter optimization, explainable AI (XAI) analysis, and post-training model vulnerabilities detection. Simplatab requires no coding expertise, provides detailed performance reports, and includes robust data bias detection, making it particularly suitable for clinical applications.
resultsEvaluated on a large pan-European cohort of 4816 patients from 12 clinical centers, Simplatab supports multiple machine learning algorithms. The most notable features that differentiate Simplatab include ease of use, a user interface accessible to those with no coding experience, comprehensive reporting, XAI integration, and thorough bias assessment, all provided in a human-understandable format.
conclusionsOur findings indicate that Simplatab can significantly enhance the usability, accountability, and explainability of machine learning in clinical settings, thereby increasing trust and accessibility for AI non-experts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.